Product NDC: | 63323-405 |
Proprietary Name: | Clonidine Hydrochloride |
Non Proprietary Name: | CLONIDINE HYDROCHLORIDE |
Active Ingredient(s): | 100 ug/mL & nbsp; CLONIDINE HYDROCHLORIDE |
Administration Route(s): | EPIDURAL |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-405 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200673 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110708 |
Package NDC: | 63323-405-10 |
Package Description: | 1 VIAL in 1 CARTON (63323-405-10) > 10 mL in 1 VIAL |
NDC Code | 63323-405-10 |
Proprietary Name | Clonidine Hydrochloride |
Package Description | 1 VIAL in 1 CARTON (63323-405-10) > 10 mL in 1 VIAL |
Product NDC | 63323-405 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CLONIDINE HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | EPIDURAL |
Start Marketing Date | 20110708 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | CLONIDINE HYDROCHLORIDE |
Strength Number | 100 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |